Københavns Lufthavne A/S
Notification on publication of statement by the Board of Directors in respect of mandatory public takeover offer
Notification on publication of statement by the Board of Directors in respect of mandatory public takeover offer
With reference to the announcement of 28 October 2025 regarding the publication of the offer document in respect of the mandatory public takeover offer made by the Kingdom of Denmark, via the Ministry of Finance, Københavns Lufthavne A/S today publishes a statement by the board of directors prepared in accordance with section 23 of the Danish Executive Order no. 614 of 2 June 2025 on takeover offers (in Danish: Bekendtgørelse nr. 614 af 2. juni 2025 om overtagelsestilbud).
COPENHAGEN AIRPORTS A/S
P.O. Box 74
Lufthavnsboulevarden 6
DK-2770 Kastrup
Contact:
Lars Nørby Johansen
Chairman of the Board of Directors
Telephone: +45 32312800
E-mail: cphpresse@cph.dk
www.cph.dk
CVR no. 14 70 72 04
Attachments
- Notification on publication of statement by the Board of Directors in respect of mandatory public takeover offer
- CPH Board Statement (ENG)
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Investeringsforeningen StockRate Invest13.11.2025 14:13:15 CET | Pressemeddelelse
Investeringsforeningen StockRate Invest - Prospekt
Freshworks Inc13.11.2025 14:00:00 CET | Press release
Freshworks Launches AI-Powered Capabilities to Elevate the Employee Experience and Turn Complexity into Growth
VCI Global Limited13.11.2025 14:00:00 CET | Press release
Tether-Backed OOBIT Token Trading Live on Kraken; VCI Global Reports US$109.8 Million Unrealized Gain from Initial US$50 Million Digital-Treasury Deployment
Freshworks Inc13.11.2025 14:00:00 CET | Press release
Freshworks Launches New AI Capabilities to Minimize Customer Service Fragmentation and Deliver Faster, More Personal Support
Matisse Pharmaceuticals13.11.2025 14:00:00 CET | Press release
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom